Elad Ben Hofstetter - 18 Mar 2026 Form 3 Insider Report for Innoviz Technologies Ltd. (INVZ)

Role
Chief Business Officer
Signature
/s/ Dafna Raz - Attorney-in-Fact
Issuer symbol
INVZ
Transactions as of
18 Mar 2026
Net transactions value
$0
Form type
3
Filing time
18 Mar 2026, 18:33:43 UTC
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Hofstetter Elad Ben Chief Business Officer C/O INNOVIZ TECHNOLOGIES LTD., 5 URI ARIAV STREET, BUILDING C, ROSH HA'AIN, ISRAEL /s/ Dafna Raz - Attorney-in-Fact 18 Mar 2026 0002030148

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding INVZ Ordinary Shares 232,144 18 Mar 2026 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding INVZ Share Option 18 Mar 2026 Ordinary Shares 21,072 $0.5695 Direct F3
holding INVZ Share Option 18 Mar 2026 Ordinary Shares 21,072 $1.14 Direct F3
holding INVZ Share Option 18 Mar 2026 Ordinary Shares 15,792 $1.14 Direct F3
holding INVZ Share Option 18 Mar 2026 Ordinary Shares 46,896 $8.50 Direct F3
holding INVZ Share Option 18 Mar 2026 Ordinary Shares 21,392 $5.23 Direct F4
holding INVZ Share Option 18 Mar 2026 Ordinary Shares 26,800 $4.03 Direct F5
holding INVZ Share Option 18 Mar 2026 Ordinary Shares 40,160 $0.7500 Direct F6
holding INVZ Share Option 18 Mar 2026 Ordinary Shares 44,016 $1.61 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 143,906 ordinary shares issuable upon vesting of restricted share units ("RSUs"); of which (a) 3,564 RSUs granted August 9, 2022, vesting in equal quarterly installments through 2026; (b) 11,388 RSUs granted August 1, 2023, vesting quarterly through 2027; (c) 12,288 RSUs granted February 27, 2024, with 2,384 vesting quarterly through 2027 and 9,904 vesting quarterly through 2028; (d) 23,430 RSUs granted August 20, 2024, vesting quarterly through 2028; (e) 12,372 RSUs granted February 25, 2025, vesting quarterly through 2029; (f) 41,072 RSUs granted August 5, 2025, one-fourth vesting on August 5, 2026, remainder vesting quarterly through 2029; and (g) 39,792 RSUs granted November 11, 2025, one-fourth vesting on November 11, 2026, remainder vesting quarterly through 2029. Vesting is subject to the Reporting Person remaining a service provider of the Issuer on each applicable vesting date. Each RSU represents a contingent right to receive one ordinary share.
F2 No exercise price is applicable.
F3 Immediately exercisable.
F4 Share options granted on August 9, 2022. Includes 18,718 vested options, and 2,674 unvested options, which shall vest in equal quarterly installments through 2026, subject to the Reporting Person remaining a service provider of the Issuer on each applicable vesting date.
F5 Share options granted on August 1, 2023. Includes 16,750 vested options, and 10,050 unvested options, which shall vest in equal quarterly installments through 2027, subject to the Reporting Person remaining a service provider of the Issuer on each applicable vesting date.
F6 Share options granted on August 20, 2024. Includes 15,060 vested options, and 25,100 unvested options, which shall vest in equal quarterly installments through 2028, subject to the Reporting Person remaining a service provider of the Issuer on each applicable vesting date.
F7 Share options granted on August 5, 2025. Includes no vested options, and 44,016 unvested options, with one-fourth of the options vesting on August 5, 2026, and the remaining shall vest in equal quarterly installments through 2029, subject to the Reporting Person remaining a service provider of the Issuer on each applicable vesting date.

Remarks:

[Exhibit 24 - Power of Attorney.]